Sagimet Biosciences, Inc. (SGMT)
10.80
-0.29
(-2.61%)
USD |
NASDAQ |
Sep 21, 16:00
10.80
0.00 (0.00%)
After-Hours: 20:00
Sagimet Biosciences Market Cap : 667.26M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 685.17M |
| September 17, 2026 | 690.12M |
| September 16, 2026 | 646.25M |
| September 15, 2026 | 646.25M |
| September 14, 2026 | 672.20M |
| September 11, 2026 | 672.20M |
| September 10, 2026 | 683.32M |
| September 09, 2026 | 670.96M |
| September 08, 2026 | 661.69M |
| September 04, 2026 | 675.90M |
| September 03, 2026 | 674.67M |
| September 02, 2026 | 678.99M |
| September 01, 2026 | 648.72M |
| August 31, 2026 | 633.89M |
| August 28, 2026 | 651.81M |
| August 27, 2026 | 664.17M |
| August 26, 2026 | 670.96M |
| August 25, 2026 | 635.75M |
| August 24, 2026 | 630.80M |
| August 21, 2026 | 633.27M |
| August 20, 2026 | 628.95M |
| August 19, 2026 | 653.66M |
| August 18, 2026 | 653.66M |
| August 17, 2026 | 644.40M |
| August 14, 2026 | 651.81M |
| Date | Value |
|---|---|
| August 13, 2026 | 573.35M |
| August 12, 2026 | 580.14M |
| August 11, 2026 | 588.17M |
| August 10, 2026 | 591.26M |
| August 07, 2026 | 559.75M |
| August 06, 2026 | 539.98M |
| August 05, 2026 | 281.54M |
| August 04, 2026 | 260.35M |
| August 03, 2026 | 232.98M |
| July 31, 2026 | 231.68M |
| July 30, 2026 | 238.20M |
| July 29, 2026 | 229.40M |
| July 28, 2026 | 236.89M |
| July 27, 2026 | 242.76M |
| July 24, 2026 | 230.38M |
| July 23, 2026 | 228.42M |
| July 22, 2026 | 229.72M |
| July 21, 2026 | 230.38M |
| July 20, 2026 | 233.31M |
| July 17, 2026 | 254.82M |
| July 16, 2026 | 249.28M |
| July 15, 2026 | 260.35M |
| July 14, 2026 | 252.70M |
| July 13, 2026 | 232.98M |
| July 10, 2026 | 240.15M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.543B |
| Alnylam Pharmaceuticals, Inc. | 32.66B |
| Anika Therapeutics, Inc. | 277.30M |
| Savara, Inc. | 1.120B |
| Vericel Corp. | 2.023B |
Market Cap Related Metrics
| Price to Book Value | 2.605 |
| Price | 10.80 |
| Earnings Yield | -11.87% |